Impact of switching antiplatelet therapy in acute coronary syndrome patients with different CYP2C19 phenotypes: insights from a single-center study
Our study provides preliminary evidence on favoring ticagrelor continuation and increased TVR upon aspirin withdrawal in IM.
Authors
- Shanmugasundram Sadhanandham
- Venu Seenappa
- Nagendra Boopathy Senguttuvan (ORCID: https://orcid.org/0000-0003-4979-596X)
- Asuwin Anandaram (ORCID: https://orcid.org/0009-0006-9001-0342)
- Bharath Raj Kidambi (ORCID: https://orcid.org/0000-0002-5880-2503)
- Manokar Panchanatham (ORCID: https://orcid.org/0000-0001-8893-3013)
- Yogapriya Chidambaram (ORCID: https://orcid.org/0009-0007-7025-9906)
- Pavitraa Saravana Kumar
- Nithesh Kumar
- Ramesh Sankaran (ORCID: https://orcid.org/0000-0003-0139-2715)
- Vettriselvi Venkatesan (ORCID: https://orcid.org/0000-0003-2827-8680)
- Rammurthy Anjanappa
- Gautam Ganesan Karthikeyan
- Sadagopan Thanikachalam
- Muralidharan Thoddi Ramamurthy
- Madhesh Kasi
Institutions
- Lehigh Valley Hospital-Pocono (US)
- Sri Ramachandra Institute of Higher Education and Research (IN)
- Lehigh Valley Health Network (US)
- Pushpawati Singhania Research Institute (IN)
- Sooriya Hospital (IN)
- SciGenom Labs (India) (IN)
Publication Details
- Journal
- Pharmacogenetics and Genomics
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1097/fpc.0000000000000564
- Citations
- 1
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.39